trihexyphenidyl has been researched along with Apoplexy in 1 studies
Trihexyphenidyl: One of the centrally acting MUSCARINIC ANTAGONISTS used for treatment of PARKINSONIAN DISORDERS and drug-induced extrapyramidal movement disorders and as an antispasmodic.
| Excerpt | Relevance | Reference |
|---|---|---|
| "These eye movement disorders can result in difficulty maintaining the normal ocular position and difficulty moving the eyes appropriately." | 2.47 | Interventions for disorders of eye movement in patients with stroke. ( Angilley, J; Dhillon, B; Hazelton, C; Henderson, CA; Langhorne, P; Livingstone, K; Munro, FA; Orr, H; Pollock, A; Rowe, FJ; Shahani, U, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pollock, A | 1 |
| Hazelton, C | 1 |
| Henderson, CA | 1 |
| Angilley, J | 1 |
| Dhillon, B | 1 |
| Langhorne, P | 1 |
| Livingstone, K | 1 |
| Munro, FA | 1 |
| Orr, H | 1 |
| Rowe, FJ | 1 |
| Shahani, U | 1 |
1 review available for trihexyphenidyl and Apoplexy
| Article | Year |
|---|---|
Interventions for disorders of eye movement in patients with stroke.
Topics: Activities of Daily Living; Adult; Humans; Muscarinic Antagonists; Ocular Motility Disorders; Random | 2011 |